Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
• Proprietary high productivity, fully released GMP MCBs,
suspension & adherent cells (HEK293, 293T)
• 4 AAV production patents
• Strong GMP plasmid expertise
• Strong GMP AAV track records
• Experts for lentivirus, retrovirus and adenovirus
Language:
English
Who can attend? Everyone
Featured Presenters
Business Development Manager
James Cody joined Vigene's GMP services division as a Business Development Manager in Nov. 2018. Dr. Cody's scientific background is in cancer gene therapy, having completed a Ph.D. in adenoviral vector engineering for oncolytic virotherapy and postdoctoral research on oncolytic HSV. He has a long-standing interest in gene therapy and is eager to assist Vigene's clients in making their innovative new therapies a clinical reality.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents